Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Xinghuan Wang and Jianying Huang.
Xinghuan Wang
Connection Strength
0.344
Jianying Huang
  1. Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study. Cell Prolif. 2020 Dec; 53(12):e12947.
    View in: PubMed
    Score: 0.228
  2. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. Lancet Infect Dis. 2021 12; 21(12):1654-1664.
    View in: PubMed
    Score: 0.060
  3. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020 08 15; 396(10249):479-488.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.